Navigation Links
For sharper pictures of the body's interior
Date:1/28/2009

Below in the Annex: ("We are breaking new ground in research"), you will find an interview with PTB project head Dr. Bernd Ittermann on the opportunities and risks of the whole-body tomographs of the new 7-tesla generation at the Max-Delbrck-Centrum (Max Delbrck Center) in Berlin.

Snap-shots of a diseased heart or deep insights into cancer cells a 7-tesla magnetic resonance tomograph promises scientists novel possibilities. The magnetic field of this so-called ultra-high field magnetic resonance tomograph (MRT) is 140 000 times as strong as that of the Earth and can make the most minute structures of the human body visible. This facilitates not only the development of possibilities for diagnosis and therapy in the case of brain and cancer diseases, but also opens up completely new possibilities, among other things, in cardiac research. One of the project partners is the Physikalisch-Technische Bundesanstalt (PTB, the National German Metrology Institute), whose scientists want to explore the technical possibilities of the new device and make it useful for clinical application. This week, the corresponding research building in the Experimental and Clinical Research Center of the Max-Delbrck-Centrum fr Molekulare Medizin (Max Delbrck Center for Molecular Medicine) in Berlin-Buch was dedicated during a visit by the Federal Research Minister Annette Schavan.

As the fourth 7-tesla MRT worldwide (after Boston, Pittsburgh and Paris), the Berlin System is equipped with an 8-channel transmitter system, and with this technology the cardiac imaging by means of 7-tesla MRT moves into the public eye for the first time. New research ground could also be broken in the representation of molecular processes in the body, for example in combating tumours. Bernd Ittermann, head of the Department of Medical Metrology at the PTB, explains: "So far there are only about 30 magnetic resonance tomographs with such a high magnetic field strength, and most of them are used for brain research". The new whole-body MRT at the Max Delbrck Center is to, however, have considerably more widespread use. The machine will provide pictures of extremely high resolution from the interior of the body of test persons. The researchers expect to receive insights into the development of diseases and the metabolic processes involved.

In clinics, MRT machines with 1.5 or 3 tesla (that is the unit for the magnetic flux) are customary. The 7-tesla tomograph will at first be purely a research instrument in order to explore the possibilities of the ultra-high-field magnetic resonance tomography. It is the only machine worldwide of the modern 7-tesla generation in which also a metrology institute is involved. "I find exemplary how physicians, physicists, mathematicians and engineers of the involved institutes have joined forces here in order to open up a new dimension in medical diagnostics", rejoiced PTB President Professor Dr. Ernst Gbel.

The stray magnetic field of the magnet, weighing 32 tonnes is so strong that all objects containing iron are strongly prohibited in its direct proximity. Only outside of a cage nearly five meters high and 14 meters long and made of 250 tonnes of steel is the field shield strong enough, for example, for the operation of computers.

The project partners are in addition to the Max Delbrck Center and the PTB, also the Berlin Charit, the Leibnizinstitut fr Molekulare Pharmakologie (Leibniz Institute of Molecular Pharmacology) and the Siemens company.


'/>"/>

Contact: Dr. Bernd Ittermann
Bernd.Ittermann@ptb.de
49-303-481-7318
Physikalisch-Technische Bundesanstalt (PTB)
Source:Eurekalert

Related medicine news :

1. The Help Groups Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins
2. Harpo Productions and Sony Pictures Television Announce Agreement to Launch DR. OZ
3. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: